Antiviral Responses of Tissue-resident CD49a + Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease (2023)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202205-0848oc
PubMed Identifier: 36170617
Publication URI: http://europepmc.org/abstract/MED/36170617
Type: Journal Article/Review
Parent Publication: American Journal of Respiratory and Critical Care Medicine
Issue: 5
ISSN: 1073-449X